Sarah Cannon Research Institute

Sarah Cannon Research Institute

Company type	Division
Industry	Clinical research, Healthcare
Founded	2004
Headquarters	Nashville , United States
Key people	Dee Anna Smith (CEO)
Products	Clinical research services in oncology, cardiology, gastroenterology, and other therapeutic disciplines
Number of employees	350+
Parent	Hospital Corporation of America (HCA)

Sarah Cannon Research Institute (SCRI), based in Nashville, Tennessee, operates as a division of Hospital Corporation of America with a focus on clinical research in oncology, cardiology, gastroenterology, and various other therapeutic disciplines. Led by CEO Dee Anna Smith, SCRI dedicates its efforts to advancing treatments, including the evaluation of experimental pharmaceuticals.

In 2009, SCRI enrolled more than 2,500 individuals in cancer-related studies, with over 500 participating in Phase I trials, alongside nearly 1,500 patients involved in non-oncology research. This brought the total number of participants close to 4,000 for that year. Since 1999, the institute has executed upwards of 400 pioneering "first-in-human" studies and played a role in the approval of approximately ten new medications.

With a workforce exceeding 350 employees, SCRI achieved the No. 4 position on NashvillePost magazine's 2010 Best Employers list for Middle Tennessee and was recognized by Modern Healthcare as one of the Best Places to Work in Healthcare for both 2009 and 2010. The organization's approach centers on community-oriented research and forming strategic alliances to facilitate drug development and broaden its market presence.

History

Founded in 2004 as a collaborative effort between Tennessee Oncology and HCA, SCRI derives its name from comedian Sarah Cannon (also known as Minnie Pearl). The institute builds upon Tennessee Oncology’s research initiatives dating back to 1993 through the Minnie Pearl Research Network.

In 2008, SCRI initiated a cardiovascular program establishing key locations at Redmond Regional Medical Center (Rome, Georgia), Centennial Heart (Nashville, Tennessee), and Osceola Regional Medical Center (Kissimmee, Florida).

The Global Services division was introduced in 2010 to provide comprehensive support including project management, clinical monitoring, data handling, biostatistics, safety oversight, medical writing, quality assurance, and global data safety monitoring board services.

Headquarters

SCRI’s central office is situated in Nashville, Tennessee, while its multi-specialty operations are headquartered in Memphis. Additionally, Sarah Cannon Research UK functions out of London.

Other locations

The institute partners with 57 sites across 24 U.S. states and the United Kingdom, encompassing six oncology-focused and eleven multi-specialty strategic locations.

Oncology strategic sites include:

• Tennessee Oncology – Nashville, Tennessee
• Florida Cancer Specialists – Fort Myers, Florida
• Oncology Hematology Care – Cincinnati, Ohio
• Chattanooga Oncology and Hematology Associates – Chattanooga, Tennessee
• South Carolina Oncology Associates – Columbia, South Carolina
• Virginia Cancer Institute – Richmond, Virginia
• Hope Women's Cancer Center and Sarah Cannon Cancer Center – Asheville, North Carolina

Multi-specialty strategic sites include:

• Memphis Gastroenterology Group and Gynecology & Obstetrics – Memphis, Tennessee
• Gastrointestinal Associates – Jackson, Mississippi
• The Frist Clinic – Nashville Gastroenterology – Nashville, Tennessee
• Digestive Health Specialists – Tupelo, Mississippi
• Centennial Heart – Nashville, Tennessee
• Redmond Regional Hospital Harbin Clinic – Rome, Georgia
• SCRI Research Center and Dermatology East – Germantown, Tennessee
• The Jackson Clinic – Jackson, Tennessee
• The Women's Clinic – Ft. Collins, Colorado

External links

• Sarah Cannon Research Institute